Scientific Program - Epilepsy

Print
Please see below the CONy Scientific Program. Please click on the appropriate section (ordered by ABC) to view the relevant program. Please note that the program and timing is subject to change. To view the program timetable, please click here
 

Section Heads: Thanos Covanis, Greece & Michael Sperling, USA
FRIDAY, MARCH 24, 2017
Hall B
09:00-11:00
DIAGNOSIS OF EPILEPSY
Chairs: Sophia Markoula, Greece; Andriy Dubenko, Ukraine
Debate: Should we give a diagnosis of epilepsy to someone who has had only one seizure?
Capsule:
The fundamental concept of epilepsy has been a tendency to seizures recurrence, demonstrated by an individual experiencing at least two seizures. Should this definition be altered as recommended by the ILAE to allow the diagnosis after a single seizure if there is a high probability of recurrence, or, given the plethora of potentially adverse social consequences of such a diagnosis, is it better to wait for a second seizure?
Host: Thanos Covanis, Greece
One seizure is enough: Alla Guekht, Russia
No: William Theodore, USA
Discussion and rebuttals


Debate: Can psychogenic non-epileptic seizures be diagnosed by assessing behavior without concomitant EEG recording?
Capsule: The gold standard for diagnosis of psychogenic seizures has been to obtain EEG and video with testing during an attack. However, are certain behaviors pathognomonic for psychogenic non-epileptic seizures such that simultaneous video-EEG recording is unnecessary and redundant?
Host: Miri Neufeld, Israel
Behavior may be enough: Joanna Jedrzejczak, Poland
Never: Manjari Tripathi, India

Discussion and rebuttals

11:15-13:15 TREATMENT AND PROGNOSIS OF EPILEPSY
Chair: Vassiios Kimiskidis, Greece (TBC)
Debate: Does generic drug substitution pose risk in epilepsy?
Capsule: Generic antiepileptic drugs are less expensive than brand name medication and reduce health care expenditure. Does bioequivalence translate to therapeutic equivalence, so that it is safe to substitute one generic for another or a brand name medication?
Host: Michael Sperling, USA
Yes: Martin Holtkamp, UK
No: William Theodore, USA
Discussion and rebuttals


Debate: Can medical marijuana or cannabidiol be recommended for treatment of epilepsy?
Capsule:
Marijuana has achieved popular recognition as a treatment for epilepsy, and many
government jurisdictions have approved its use. What is the quality of the evidence, and should we advise marijuana or cannabidiol for people whose seizures remain uncontrolled by conventional drugs?
Host: Thanos Covanis, Greece
Yes: Martin Brodie, UK
No: Elinor Ben-Menachem, Sweden
Discussion and rebuttals

15:00-17:00
EPILEPSY THERAPY AND ITS WITHDRAWAL
Chair: Stelianos Giannakodimos, Greece (TBC)
Debate: Should we treat electrographic subclinical seizures?
Capsule: It is common to observe subclinical electrographic seizures in people with epilepsy and in the intensive care unit. If these are subclinical, do they merit treatment? What is the evidence that they pose harm?
Host: Martin Holtkamp, UK
Pro: Ilan Blatt, Israel
Not always: Konrad Rejdak, Poland

Discussion and rebuttals
Debate: Should antiepileptic drugs usually be withdrawn after 2 years of seizure freedom?

Host: Elinor Ben-Menachem, Sweden
Pro: Ilan Blatt, Israel (TBC)
Con: Michael Sperling, USA
Discussion and rebuttals

17:00-19:00
EPILEPSY: UNRESOLVED AND INTERESTING
Chairs: Alexandros Agathonikou, Greece (TBC);
Željka Petelin Gadže,
Croatia
Debate: Should valproate ever be prescribed to women of childbearing age?
Capsule:
Valproate has been associated with fetal malformations and cognitive impairment in offspring of women who took this agent while pregnant. On the other hand, it is a remarkably effective drug for some types of epilepsy. Does its superior efficacy warrant its use in women who may become pregnant?
Host: Alla Guekht, Russia
Can be used in several cases: Martin Brodie, UK
Never: Ivan Rektor, Czech Republic

Discussion and rebuttals

Case Studies

SUNDAY, MARCH 26, 2017
HALL A
08:30-10:30
PLENARY LECTURES: EPILEPSY

Chair: Argyris Dinopoulos, Greece
The importance of cardiovascular fitness in the prevention and treatment of epilepsy and co-morbidities
Elinor Ben-Menachem, Sweden

Do antiepileptic drug trials adequately measure Efficacy and Adverse Effects?
Michael Sperling, USA

SEEG vs. subdural EEG implantation
Elson So, USA

10:00-10:30 Coffee Break

Is diabetes directly affecting the risk of AD?
Zoe Arvanitakis, USA

What can genetics teach us about human memory?
Andreas Papassotiropoulos, Switzerland

11:30-14:00 DEBATES: EPILEPSY
Debate: Is responsive stimulation, either by recording from heart or brain, superior to non-responsive stimulation?
Capsule: Stimulation can be given at automatic, prescribed intervals irrespective of ongoing brain signals or in response to specific alterations in the EEG. Does the evidence support the superiority of one type of stimulation over the other?
Host: Paul Boon, Belgium
Pro Responsive Stimulation: Kristl Vonck, Belgium

Con: Michael Sperling, USA
Discussion and rebuttals

Debate: Neurostimulation should be used early in the treatment of epilepsy once medication resistance is apparent, after failure of 2-3 drugs.
Host: TBA
Pro: Kristl Vonck, Belgium (TBC)
Con: Ivan Rektor, Czech Republic (TBC)
Discussion and rebuttals

14:30 POSTER AWARDS & CLOSING CEREMONY